Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report) traded down 5.9% during mid-day trading on Wednesday . The stock traded as low as $4.28 and last traded at $4.28. 389,264 shares were traded during trading, a decline of 35% from the average session volume of 594,387 shares. The stock had previously closed at $4.55. Analyst […]
Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report) traded up 5.3% during mid-day trading on Wednesday . The company traded as high as $2.98 and last traded at $2.97. 128,382 shares were traded during trading, a decline of 76% from the average session volume of 530,313 shares. The stock had previously closed at $2.82. Wall […]
Innovis Asset Management LLC lessened its holdings in shares of Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) by 49.9% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 63,179 shares of the company’s stock after selling 62,927 shares during […]
Autolus Therapeutics (NASDAQ:AUTL – Get Free Report) and Editas Medicine (NASDAQ:EDIT – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk and institutional ownership. Institutional & Insider Ownership 64.8% of Autolus […]
Armistice Capital LLC cut its stake in shares of Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) by 5.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,672,000 shares of the company’s stock after selling 552,000 shares during the period. […]